Caspases are cysteine proteases with critical roles in apoptosis. The Caenorhabditis elegans caspase CED-3 is activated by autocatalytic cleavage, a process enhanced by CED-4. Here we report that the CED-3 zymogen localizes to the perinuclear region in C. elegans germ cells and that CED-3 autocatalytic cleavage is held in check by C. elegans nuclei and activated by CED-4. The nuclear-pore protein NPP-14 interacts with the CED-3 zymogen prodomain, colocalizes with CED-3 in vivo and inhibits CED-3 autoactivation in vitro. Several missense mutations in the CED-3 prodomain result in stronger association with NPP-14 and decreased CED-3 activation by CED-4 in the presence of nuclei or NPP-14, thus leading to cell-death defects. Those same mutations enhance autocatalytic cleavage of CED-3 in vitro and increase apoptosis in vivo in the absence of npp-14. Our results reveal a critical role of nuclei and nuclear-membrane proteins in regulating the activation and localization of CED-3.
Apoptotic caspases are a family of conserved cysteine proteases that play central roles in activating and executing apoptosis in diverse organisms 1, 2 . They are initially synthesized as inactive zymogens containing an N-terminal prodomain or caspase-recruitment domain (CARD) and two catalytic subunits known as the large and small subunits. In cells that receive cell-death stimuli, caspase zymogens either undergo autoproteolytic activation, through induced dimerization or oligomerization of the zymogens, or are proteolytically activated by upstream caspases or proteases 1, 2 . The activated caspases then act by cleaving a plethora of cellular proteins, thereby leading to self-destruction of the cell, including nuclear-membrane breakdown, chromosome fragmentation, apoptotic-body formation and clearance by phagocytes 3 . Given the critical roles of caspases in apoptosis, the activation and activity of caspases are tightly regulated at multiple levels and by both positive and negative regulators, so that they are suppressed in cells that will live but are rapidly activated in cells that will undergo apoptosis 1, 2 .
The C. elegans ced-3 gene is essential for apoptosis and encodes the first apoptotic caspase to be identified 4, 5 . The analysis of CED-3 activation and regulation during apoptosis has provided critical insights into the activation and functions of caspases and apoptosis in general. In C. elegans cells that live, the CED-4 protein, a homolog of the human apoptotic protease activating factor-1 (Apaf-1) 6, 7 , forms a 2:1 stoichiometric complex with the cell-death inhibitor CED-9 and is tethered to the mitochondrial surface through CED-9 (refs. [8] [9] [10] [11] [12] . During apoptosis, the cell-death initiator EGL-1 is transcriptionally upregulated, binds CED-9 and triggers dissociation of the CED-4 dimer from CED-9 (refs. 11-13) . Released CED-4 dimers subsequently oligomerize and relocate to the perinuclear region, where they activate apoptosis 11, 12, 14 . It is not understood why CED-4 relocates to nuclei during apoptosis.
Several key questions remain unanswered regarding how CED-3 relates to the dynamic movement of CED-4 during apoptosis. In particular, the subcellular localization of CED-3 in C. elegans, which would shed light on how CED-3 is activated and how it causes apoptosis, has been a mystery. In addition, the role of the prodomain of the CED-3 zymogen in C. elegans apoptosis is enigmatic, because the prodomain of CED-3 appears to be completely dispensable for CED-3 activation and activity in vitro 15, 16 , yet it is critical for the killing activity of CED-3 in vivo 4, 17 .
In this study, we set out to investigate where CED-3 localizes and how the prodomain of CED-3 affects apoptosis. We found that CED-3 localizes to the perinuclear region in C. elegans germ cells, thus providing an explanation for the relocation of CED-4 oligomers to nuclei during apoptosis. Moreover, we identified a nuclear-pore protein, NPP-14, that is critical not only for the perinuclear localization of CED-3 but also for the inhibition of CED-3 zymogen autoactivation in living cells. Finally, we demonstrated that several unique CED-3 prodomain mutations enhance binding of the CED-3 zymogen to NPP-14, thereby leading to inhibition of CED-4-induced CED-3 activation in vitro and apoptosis in vivo.
RESULTS

CED-3 prodomain mutations can enhance CED-3 autoactivation
Several loss-of-function (lf) mutations in ced-3 (n718, n1040 and n2439) result in single-amino acid substitutions (G65R, L27F and L30F, respectively) in the prodomain of the CED-3 caspase 4, 17 . These mutations cause a strong decrease in apoptosis, as indicated by the number of persistent cell corpses in a ced-1(e1735) mutant background defective in cell-corpse clearance 18 (Table 1 Table 1 ). Because the prodomain of CED-3 appears to be dispensable for CED-3 activity or activation in vitro 15, 16 , these results raise important questions regarding the role of the CED-3 prodomain in regulating CED-3 activation, activity and apoptosis in vivo.
We first performed in vitro assays to examine whether these prodomain mutations would affect autoproteolytic activation of the CED-3 zymogen or CED-3 activation induced by oligomeric CED-4, the activated form of CED-4 (ref. 12). In CED-3 autoactivation assays, [ 35 S]methionine-labeled CED-3 zymogen synthesized in a rabbit reticulocyte lysate system initially existed as an unprocessed precursor and was slowly autocleaved into some processed forms, including one form migrating at 19) that was visible by the 90-min time point (Fig. 1a, lanes 1-4, and Supplementary Fig. 1a,c) . In contrast, CED-3(L27F), CED-3(L30F) and CED-3(G65R) zymogens displayed much stronger autoproteolytic activation and were mostly autoprocessed by the 90-min time point (Fig. 1a , lanes 5-12 and 17-20, and Supplementary Fig. 1a,c) . This result was unexpected because these mutations strongly decreased rather than promoted cell death in vivo ( Table 1 and Supplementary Table 1 ). Another CED-3 prodomain mutation, n2449 [R51H] , caused a scarcely detectable cell-death defect ( Table 1 and Supplementary Table 1) , and the CED-3(R51H) zymogen was indistinguishable from the wild-type CED-3 zymogen in the CED-3 autoactivation assay (Fig. 1a, lanes  13-16, and Supplementary Fig. 1a,c) .
Prodomain mutations do not impair CED-3 activation by CED-4
Given the strong cell-death defects caused by these three CED-3 prodomain mutations, we examined whether these mutations might impair the activation of the CED-3 zymogen induced by CED-4. Similarly to previously reported results 12, 15, 20 , oligomeric CED-4 markedly accelerated autoproteolytic activation of both the wild-type CED-3 zymogen and the CED-3(R51H) zymogen (Fig. 1b, lanes 1-4 and 13-16 , and Supplementary Fig. 1b,c) , thereby leading to the activation of some of the CED-3 zymogens at the 25-min time point (Fig. 1b,  lane 1) , when there was no sign of any CED-3 activation in the absence of CED-4 (Fig. 1a, lane 1) . In comparison, oligomeric CED-4 only mildly enhanced autoproteolytic activation of CED-3(L27F), CED-3(L30F) and CED-3(G65R) zymogens (Fig. 1b , lanes 5-12 and 17-20, and Supplementary Fig. 1b,c) , which were already selfactivated strongly in vitro in the absence of CED-4 (Fig. 1a , lanes 5-12 and 17-20, and Supplementary Fig. 1a,c) . Therefore, in the presence of oligomeric CED-4, all five CED-3 zymogens were activated to a similar level. In contrast, the G360S catalytic-site mutation in CED-3, conferred by the strong lf mutation n2433, completely blocked CED-3 zymogen activation in the presence or absence of CED-4 ( Table 1 and Supplementary Fig. 1d ). These results indicate that the three CED-3 prodomain mutations (G65R, L27F and L30F) unexpectedly enhanced CED-3 autoproteolytic activation and did not affect CED-4-induced CED-3 activation in vitro. These findings are inconsistent with the strong cell-death defects caused by these mutations and suggest that these mutations impair CED-3 activation or activity in vivo through a more complex mechanism that was not recapitulated in the in vitro assays.
CED-3 displays perinuclear localization in germ cells
To understand how CED-3 kills cells, we examined the subcellular localization pattern of CED-3 in C. elegans, using a low-copy integrated transgene expressing a CED-3 translational GFP fusion (P ced-3 ced-3:: gfp), which we generated by biolistic bombardment 21 . This transgene fully rescued the cell-death defect of the strong ced-3(n2433) mutant (Supplementary Table 2 ), thus indicating that this CED-3::GFP fusion is functional and probably localizes to the proper subcellular sites. Interestingly, we observed a perinuclear localization pattern of CED-3:: GFP in C. elegans germ cells ( Fig. 2a) , which was not present when GFP was expressed in germ cells ( Supplementary Fig. 2a,b) . This perinuclear localization pattern of CED-3::GFP was lost and became diffuse in apoptotic germ cells (Supplementary Fig. 2c ), probably because of breakdown of the nuclear membrane during apoptosis 3 . Although CED-3::GFP expressed from a high-copy-number transgene has been observed in the cytoplasm of some dying cells and their mothers in C. elegans embryos 22 , we did not detect a clearly visible GFP signal in live somatic cells of C. elegans embryos, larvae or adults carrying the low-copy P ced-3 ced-3::gfp transgene. Multiple efforts to generate antibodies to CED-3 failed to produce an antibody able to detect endogenous CED-3 expression in C. elegans through either immunoblotting or immunohistochemistry (Online Methods).
C. elegans nuclei inhibit CED-3 autoactivation in vitro
Given the perinuclear localization pattern of CED-3, we examined whether C. elegans nuclei might play a role in regulating CED-3 
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(n = 15 embryos). The significance of differences between cell-corpse numbers in strains with or without npp-14(sm160) was determined by two-sided t tests. **P < 0.0001; *P < 0.05; P > 0.05 otherwise.
A r t i c l e s
A r t i c l e s activation or activity. We purified nuclei from wild-type animals 23 ( Supplementary Fig. 2d and Online Methods) and included them in CED-3 activation or activity assays. In the absence of oligomeric CED-4, the limited self-activation of the wild-type CED-3 zymogen and the CED-3(R51H) zymogen was inhibited by C. elegans nuclei (Fig. 3a,b , lanes 1-4 and 13-16, and Supplementary Fig. 3a,b,d) . Similarly, the originally robust autoactivation of CED-3(L27F), CED-3(L30F) and CED-3(G65R) zymogens was markedly suppressed by purified nuclei (Fig. 3a,b , lanes 5-12 and 17-20, and Supplementary  Fig. 3a ,b,d), thus resulting in a loss of the processed catalytic subunits migrating at approximately [15] [16] [17] 19) . However, purified nuclei did not inhibit cleavage of CED-9, a known CED-3 substrate 24 , by the active CED-3 protease (Supplementary Fig. 2e ), thus indicating that nuclei do not affect the activity of active CED-3. These results suggest that C. elegans nuclei inhibit autoactivation of both wild-type and mutant CED-3 zymogens in vitro and may serve as a negative regulator that inhibits CED-3 autoproteolytic activation in vivo. During apoptosis, CED-4 is released from the CED-4 and CED-9 inhibitory complex tethered on the outer mitochondrial membrane, and it subsequently oligomerizes into a form able to promote CED-3 activation and cell killing 11, 12 . When we included CED-4 oligomers in the CED-3 activation assays with the nuclei, both wild-type CED-3 and CED-3(R51H) zymogens were strongly activated (Fig. 3c, lanes  1-4 and 13-16, and Supplementary Fig. 3c,d) , thus indicating that CED-4 oligomers overcame the inhibitory effect of nuclei to induce robust activation of the CED-3 and CED-3(R51H) zymogens. In contrast, CED-4 oligomers were unable to reverse the inhibition of nuclei to restore strong activation of the CED-3(L27F), CED-3(L30F) and CED-3(G65R) zymogens, and in particular, generation of catalytic subunits migrating at approximately 15-17 kDa (Fig. 3c , lanes 5-12 and 17-20, and Supplementary Fig. 3c,d ). These in vitro results are A r t i c l e s consistent with the findings that the CED-3 prodomain mutations L27F, L30F and G65R, but not R51H, caused strong cell-death defects in C. elegans ( Table 1 and Supplementary Table 1) .
NPP-14 inhibits cell death in a ced-3 allele-specific manner
We investigated how CED-3 localizes to the perinuclear region and whether inhibition of the activation of CED-3 zymogen by nuclei is mediated by a nuclear-membrane protein. Because the CED-3 G65R mutation significantly enhanced CED-3 zymogen autoactivation in the absence of C. elegans nuclei (Fig. 3a,b Supplementary Fig. 1d 
), nor did it increase the number of persistent cell corpses in ced-1(e1735); ced-3(n2449[R51H])
embryos, which expressed a CED-3 zymogen indistinguishable from the wild-type CED-3 zymogen in autoactivation in vitro (Fig. 1a,b) . Moreover, loss of npp-14 did not alter the extra cell Table 1) . Table 3 ) and resulted in a greater increase in germ-cell death when these animals were subjected to UV irradiation (Supplementary Table 4) . In germ cells, as in somatic cells, loss of npp-14 did not increase cell death in ced- Tables 3  and 4) . Together, these results show that npp-14 plays an important allele-specific role in cell-death inhibition in three ced-3 mutants (n718, n1040 and n2439) that have CED-3 zymogens with enhanced autoactivation activity.
A r t i c l e s numbers in ced-1(e1735); ced-3(n2433[G360S]) and ced-1(e1735); ced-3(n2449[R51H]) animals (Supplementary
Similarly, inactivation of npp-14 significantly increased germ-cell death in ced-1(e1735); ced-3(n1040[L27F]) and ced-1(e1735); ced-3(n2439[L30F]) animals (Supplementary
1(e1735); ced-3(n2433[G360S]) or ced-1(e1735); ced-3(n2449[R51H]) animals with or without UV irradiation (Supplementary
NPP-14 is critical for CED-3 perinuclear localization
To investigate whether npp-14 affects CED-3 subcellular localization, we introduced the P ced-3 ced-3::gfp integrated transgene into the npp-14(sm160) mutant and found that CED-3 largely lost its perinuclear localization (Fig. 2b) . This result indicated that NPP-14, a nuclear-membrane protein, is critical for localization of CED-3 to the perinuclear region. We generated a low-copy-number integrated transgene that expressed an npp-14 translational fusion with dsRed from its endogenous promoter (P npp-14 npp-14::dsRed) by biolistic bombardment and found that NPP-14::dsRed colocalized with CED-3 ::GFP in C. elegans germ cells (Fig. 2c) . We then tested whether NPP-14 directly interacted with CED-3 by using pulldown assays with glutathione S-transferase (GST)-fusion proteins. GST-NPP-14, but not GST alone, bound full-length CED-3 (residues 1-503; Supplementary Fig. 4a ) and the prodomain of CED-3 (residues 1-220; Fig. 4a , lanes 8 and 9) but did not interact with a fragment of CED-3 containing both catalytic subunits (residues 206-503; Supplementary Fig. 4a) . Interestingly, GST-NPP-14 displayed significantly stronger binding to the CED-3 prodomain containing the L27F, L30F or G65R mutation than to the wild-type CED-3 prodomain or the mutant CED-3(R51H) prodomain (Fig. 4a, lanes 10-14,  Fig. 4b, and Supplementary Fig. 4b) . These results together indicate that NPP-14 plays an important role in tethering the CED-3 zymogen to the nuclear membrane through binding to the CED-3 prodomain. The finding that NPP-14 showed stronger binding to three CED-3 zymogens with prodomain mutations that cause strong cell-death defects in vivo was consistent with the observations that these three mutant zymogens were poorly activated by oligomeric CED-4 in the presence of nuclei in vitro (Fig. 3c, lanes 5-12 and 17-20 , and Supplementary Fig. 3c,d ).
NPP-14 regulates CED-3 autoactivation in vitro
We finally tested whether NPP-14 inhibited CED-3 autoactivation in vitro, similarly to C. elegans nuclei. When we included recombinant NPP-14 in the CED-3 activation assays, the limited selfactivation of CED-3 and CED-3(R51H) zymogens was blocked (Fig. 4c,d, lanes 1-4 and 13-16, and Supplementary Fig. 5a,b,d) , and the strong self-activation of CED-3(L27F), CED-3(L30F) and CED-3(G65R) zymogens was largely suppressed (Fig. 4c,d , lanes 5-12 and 17-20, and Supplementary Fig. 5a,b,d ). In agreement with this in vitro observation, overexpression of NPP-14 in C. elegans inhibited cell death during embryogenesis (Supplementary Fig. 4c) . However, when we included CED-4 oligomers in the reactions with NPP-14, the autoproteolytic activation of CED-3 and CED-3(R51H) zymogens was greatly enhanced (Fig. 4e, lanes 1-4 and  13-16, and Supplementary Fig. 5c,d) . In contrast, the activation of the CED-3(L27F), CED-3(L30F) or CED-3(G65R) zymogen remained largely suppressed (Fig. 4e, lanes 5-12 and lanes 17-20,  and Supplementary Fig. 5c,d) . Similarly to nuclei, NPP-14 did not inhibit the activity of the active CED-3 protease ( Supplementary  Fig. 2f) . Therefore, NPP-14 mimics nuclei in suppressing CED-4-induced activation of three CED-3 zymogens with prodomain mutations that cause stronger association of CED-3 with NPP-14, but it does not affect active CED-3 protease. These results explain the paradoxical observations that CED-3(L27F), CED-3(L30F) and CED-3(G65R) zymogens strongly self-activate in vitro but have a greatly reduced proapoptotic activity in vivo. A r t i c l e s DISCUSSION Caspases play essential roles in the initiation and execution of apoptosis in diverse organisms [1] [2] [3] 30 . The activation and activities of caspases must be tightly controlled to ensure proper animal development and tissue homeostasis [1] [2] [3] 30 . How the CED-3 caspase, the prototypical apoptotic caspase and the key cell-killing protein in C. elegans, is regulated so that it is safely constrained in living cells and specifically activated in apoptotic cells has been a major topic of study. The central unresolved issue has been the CED-3 zymogen's physical location, which governs how the caspase might be activated and how it triggers apoptosis. In this study, we report that the C. elegans CED-3 zymogen is tethered to the nuclear membrane in live germ cells through its interaction with the nuclear-pore component NPP-14. This protein interaction and the nuclear-membrane association block autoactivation of the CED-3 zymogen in vitro and appear to protect cells from inadvertent apoptosis in vivo. In cells destined to undergo apoptosis, the activated CED-4 oligomers relocate from mitochondria to the perinuclear region 11, 12 or accumulate in the perinuclear region 14 , where they induce robust activation of the CED-3 zymogen by overcoming the inhibitory effects of NPP-14 and nuclei, thereby leading to the activation of apoptosis. These findings answer the long-standing questions of how autoactivation of the CED-3 zymogen is curbed in cells that live and why CED-4 relocates to the perinuclear region to activate apoptosis. To our knowledge, this is also the first study reporting that a caspase zymogen is targeted to the perinuclear region in living cells and that nuclei play a direct and critical role in regulating the appropriate activation of a caspase zymogen. In mammals, caspase zymogens have not been reported to localize to the perinuclear region or to associate with the nuclear membrane. However, several caspases, including caspase-2 and caspase-3, have been found in nuclei or in the nuclear fractions [31] [32] [33] , although the importance of this localization in apoptosis and caspase activation is unclear. Moreover, several nuclear-pore proteins, such as Nup210, Nup214 and Nup107, have been implicated in suppressing apoptosis in mammalian cells [34] [35] [36] . In particular, Nup210 plays an antiapoptotic role and promotes skeletalmuscle differentiation by suppressing the caspase cascade induced by endoplasmic reticulum stress accompanying the differentiation process 34 . Further investigation is needed to examine whether association with nuclear-membrane proteins represents a conserved mechanism for regulating apoptosis and caspase activation across organisms.
The prodomains or the CARD domains of caspases in mammals play a critical role in caspase activation by recruiting caspase zymogens to specific death-activation complexes, such as the apoptosome or death-receptor signaling complexes, thereby leading to their autocatalytic activation 1, 2, 30 . It is therefore intriguing that the prodomain of CED-3 appears to be dispensable for CED-3 activation in vitro 15, 16 , yet multiple mutations in the prodomain, including three examined in this study (n718, n1040 and n2439), cause strong cell-death defects in vivo 4, 17 . In this study, we showed that these three prodomain mutations result in stronger association of the CED-3 zymogens with NPP-14, thus deterring not only CED-3 autocatalytic activation but also CED-3 activation induced by CED-4 oligomers (Figs. 3 and 4) . This finding provides mechanistic insight into why these mutations cause strong cell-death defects in vivo. However, these three prodomain mutations also caused enhanced CED-3 autoactivation in vitro, and, in agreement with that finding, increased apoptosis in vivo in the absence of npp-14 ( Fig. 1 and Table 1 ). These findings suggest that NPP-14 and C. elegans nuclei are the key regulators of CED-3 activation and apoptosis in C. elegans and raise the possibility that a similar mechanism may control caspase activation and apoptosis in other organisms.
METHODS
Methods and any associated references are available in the online version of the paper. 
